These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38335209)
21. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289 [TBL] [Abstract][Full Text] [Related]
22. Rapid diagnostic tests for Plasmodium vivax malaria in endemic countries. Agarwal R; Choi L; Johnson S; Takwoingi Y Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013218. PubMed ID: 33146932 [TBL] [Abstract][Full Text] [Related]
23. Rapid Antigen Test LumiraDx Cattelan AM; Sasset L; Zabeo F; Ferrari A; Rossi L; Mazzitelli M; Cocchio S; Baldo V Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409513 [TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: based malaria rapid diagnostic tests in Ghana. Amoah LE; Abankwa J; Oppong A Malar J; 2016 Feb; 15():101. PubMed ID: 26891848 [TBL] [Abstract][Full Text] [Related]
26. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial. Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826 [TBL] [Abstract][Full Text] [Related]
27. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study. Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327 [TBL] [Abstract][Full Text] [Related]
28. Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda. Achan J; Serwanga A; Wanzira H; Kyagulanyi T; Nuwa A; Magumba G; Kusasira S; Sewanyana I; Tetteh K; Drakeley C; Nakwagala F; Aanyu H; Opigo J; Hamade P; Marasciulo M; Baterana B; Tibenderana JK Lancet Microbe; 2022 Jan; 3(1):e62-e71. PubMed ID: 34723228 [TBL] [Abstract][Full Text] [Related]
29. Bean Extract-Based Gargle for Efficient Diagnosis of Active COVID-19 Infection Using Rapid Antigen Tests. Kwon J; Ko E; Cho SY; Lee YH; Jun S; Lee K; Hwang E; Vaidya B; Hwang JH; Hwang JH; Kim N; Song MK; Kim HY; Ito D; Lin Y; Jo E; Yang KE; Chung HC; Cha S; Kim DI; Yi YS; Yun SH; Park SC; Lee S; Choi JS; Kim DS; Kim D Microbiol Spectr; 2022 Feb; 10(1):e0161421. PubMed ID: 35171037 [TBL] [Abstract][Full Text] [Related]
30. Evaluating performance of multiplex real time PCR for the diagnosis of malaria at elimination targeted low transmission settings of Ethiopia. Belachew M; Wolde M; Nega D; Gidey B; Negash L; Assefa A; Tasew G; Woyessa A; Abera A Malar J; 2022 Jan; 21(1):9. PubMed ID: 34986840 [TBL] [Abstract][Full Text] [Related]
31. Malaria elimination in Ghana: recommendations for reactive case detection strategy implementation in a low endemic area of Asutsuare, Ghana. Aidoo EK; Aboagye FT; Agginie GE; Botchway FA; Osei-Adjei G; Appiah M; Takyi RD; Sakyi SA; Amoah L; Arthur G; Lawson BW; Asmah RH; Boateng P; Ansah O; Krogfelt KA Malar J; 2024 Jan; 23(1):5. PubMed ID: 38167067 [TBL] [Abstract][Full Text] [Related]
32. Detecting asymptomatic carriage of Plasmodium falciparum in southern Ghana: utility of molecular and serological diagnostic tools. Agbana HB; Rogier E; Lo A; Abukari Z; Jones S; Gyan B; Aidoo M; Amoah LE Malar J; 2022 Feb; 21(1):57. PubMed ID: 35183178 [TBL] [Abstract][Full Text] [Related]
33. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer. Patriquin G; LeBlanc JJ; Williams C; Hatchette TF; Ross J; Barrett L; Davidson R Microbiol Spectr; 2022 Feb; 10(1):e0245521. PubMed ID: 35171010 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Abbott Panbio™ COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care. Eikelenboom-Boskamp A; den Ouden M; de Groot T; Stobernack T; Wertheim H; Voss A PLoS One; 2023; 18(2):e0276244. PubMed ID: 36827362 [TBL] [Abstract][Full Text] [Related]
35. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study. Venekamp RP; Veldhuijzen IK; Moons KGM; van den Bijllaardt W; Pas SD; Lodder EB; Molenkamp R; Igloi Z; Wijers C; Dos Santos CO; Debast SB; Bruins MJ; Polad K; Nagel-Imming CRS; Han WGH; van de Wijgert JHHM; van den Hof S; Schuit E BMC Med; 2022 Feb; 20(1):97. PubMed ID: 35197052 [TBL] [Abstract][Full Text] [Related]
36. [Evaluation of two COVID-19 antigenic diagnostic tests: Ngaba GP; Kalla GCM; Assob JCN; Njouendou AJ; Jembe CN; Mboudou ET; Mbopi-Keou FX Pan Afr Med J; 2021; 39():228. PubMed ID: 34630840 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
38. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study. Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731 [TBL] [Abstract][Full Text] [Related]
39. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting. Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231 [TBL] [Abstract][Full Text] [Related]
40. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay. Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]